These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 429839)

  • 41. Key molecular events in puromycin aminonucleoside nephrosis rats.
    Guan N; Ding J; Deng J; Zhang J; Yang J
    Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unilateral renal disease in the rat. II. Glomerular mesangial uptake of colloidal carbon in unilateral aminonucleoside nephrosis and nephrotoxic serum nephritis.
    Hoyer JR; Elema JD; Vernier RL
    Lab Invest; 1976 Mar; 34(3):250-5. PubMed ID: 1082531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
    Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
    Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In glomerular cells of puromycin aminonucleoside nephrosis rats both phosphorylated and total STAT3 levels increased during proteinuria.
    Saygı Hİ; Güngör ZB; Kalay F; Seçkin İ
    Acta Histochem; 2018 Aug; 120(6):595-603. PubMed ID: 30054017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of anionic sites from the glomerular basement membrane in aminonucleoside nephrosis.
    Caulfield JP; Farquhar MG
    Lab Invest; 1978 Nov; 39(5):505-12. PubMed ID: 732274
    [No Abstract]   [Full Text] [Related]  

  • 46. Activities of lysosomal enzymes in isolated glomeruli. Alterations in experimental nephrosis.
    Velosa JA; Shah SV; Ou SL; Abboud HE; Dousa TP
    Lab Invest; 1981 Dec; 45(6):522-6. PubMed ID: 7321525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules.
    Bohrer MP; Baylis C; Robertson CR; Brenner BM; Troy JL; Willis WT
    J Clin Invest; 1977 Jul; 60(1):152-61. PubMed ID: 874080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis.
    Dunér F; Lindström K; Hultenby K; Hulkko J; Patrakka J; Tryggvason K; Haraldsson B; Wernerson A; Pettersson E
    Nephron Exp Nephrol; 2010; 116(2):e42-52. PubMed ID: 20588063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glomerular podocyte cell junctions in nephrotic syndrome. I. Freeze-fracture studies in rat aminonucleoside nephrosis.
    Kühn K; Sterzel RB; Reale E
    J Submicrosc Cytol; 1981 Jul; 13(3):407-12. PubMed ID: 7334544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The permeability of glomerular capillaries of aminonuceoside nephrotic rats to graded dextrans.
    Caulfield JP; Farquhar MG
    J Exp Med; 1975 Jul; 142(1):61-83. PubMed ID: 1151287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of transcapillary fluid and solute exchange in the renal glomerulus.
    Robertson CR
    Microvasc Res; 1980 Mar; 19(2):131-41. PubMed ID: 6155592
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro effects of puromycin aminonucleoside on the ultrastructure of rat glomerular podocytes.
    Bertram JF; Messina A; Ryan GB
    Cell Tissue Res; 1990 May; 260(3):555-63. PubMed ID: 2372813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of drugs to aminonucleoside-induced nephritis].
    Aihara Y
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):895-904. PubMed ID: 3249455
    [No Abstract]   [Full Text] [Related]  

  • 54. Urine protease and antiprotease activity in experimental aminonucleoside nephrotoxicity.
    Mayer M; Yedgar S; Joffe M; Shafrir E
    Nephron; 1981; 29(5-6):223-8. PubMed ID: 7033808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in the molecular sieve of glomerular basement membrane in rats with aminonucleoside nephrosis.
    Takaya Y; Ota Z; Makino H; Kida K; Miyoshi A; Hiramatsu M; Takahashi K; Ofuji T
    Acta Med Okayama; 1980 Feb; 34(1):67-70. PubMed ID: 6446842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. mTOR inhibition with temsirolimus causes acute increases in glomerular permeability, but inhibits the dynamic permeability actions of puromycin aminonucleoside.
    Axelsson J; Rippe A; Rippe B
    Am J Physiol Renal Physiol; 2015 May; 308(10):F1056-64. PubMed ID: 25740597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Follow-up study of glomerular lesions in aminonucleoside nephrosis].
    Hirabayashi K; Ishitobi F; Takimoto T; Kure N; Iidaka K
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):387-400. PubMed ID: 3747250
    [No Abstract]   [Full Text] [Related]  

  • 58. An ultrastructural study of the effect of the steroid in puromycin aminonucleoside nephrosis rats.
    Fujiwara Y
    Virchows Arch A Pathol Anat Histopathol; 1984; 405(1):11-24. PubMed ID: 6438895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aminonucleoside nephrosis in PRO/Re mice.
    Kanwar YS; Manaligod JR; Krakower CA
    Proc Soc Exp Biol Med; 1977 Jul; 155(3):339-45. PubMed ID: 877132
    [No Abstract]   [Full Text] [Related]  

  • 60. Micropuncture study of albumin transfer in aminonucleoside nephrosis in the rat.
    Lewy JE; Pesce A
    Pediatr Res; 1973 Jun; 7(6):553-9. PubMed ID: 4708973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.